Disease Activity as A Risk Factor for Increased Arterial Stiffness in Patients with Ulcerative Colitis
https://doi.org/10.20514/2226-6704-2026-16-3-193-203
EDN: JFHORK
Abstract
Objective. We aimed to study the parameters of arterial stiffness and its variability during 24-hour monitoring in relation to the clinical and endoscopic activity of ulcerative colitis. Materials and methods. This cross-sectional retrospective study involved 100 patients with ulcerative colitis (mean age 40 [33; 49] years, 38 (38 %) men, disease duration >1 year, without concomitant cardiovascular diseases or metabolic disorders) and 50 healthy control subjects. Arterial stiffness parameters were assessed via 24-hour ambulatory blood pressure monitoring with Vasotens technology. Based on disease activity patients were divided into 3 groups: Group 1 included 30 patients in clinical and endoscopic remission; Group 2 consisted of 22 patients in clinical remission with endoscopic activity; Group 3 included 48 patients with both clinical and endoscopic exacerbation. Statistical analysis was performed using the software package “IBM SPSS Statistics Version 25.0”. Results. Increased arterial stiffness (aortic pulse wave velocity (PWVао) >10 m/s) was detected in 67 (67 %) of ulcerative colitis patients, which was significantly higher than in the control group (OR = 4.74; p<0.001). The most pronounced alterations were observed in the group with clinical-endoscopic exacerbation, which showed increased aortic pulse wave velocity at systolic blood pressure (SBP)=100 mmHg and heart rate (HR)=60 bpm (PWVао 100-60) (p=0.003), augmentation index adjusted for HR=75 bpm (AIx75) (p<0.001), and PWVао variability (p=0.002). In endoscopically active disease without clinical symptoms, AIx75, PWVао100-60, and variability of the rate of increase in blood pressure in the aorta (dP/dt var.) were significantly higher compared to controls. Logistic regression analysis identified age >40 years (p=0.001; 95 % CI: 2.045 to 15.309), disease activity of ulcerative colitis (p=0.025; 95 % CI: 1.151 to 8.200), and a positive family history of cardiovascular disease (p=0.033; 95 % CI: 1.131 to 17.312) as independent predictors of increased arterial stiffness in patients with ulcerative colitis. The prediction model demonstrated good performance: аrea under the ROC curve (AUC) = 0.76 ± 0.051 (95 % CI: 0.66–0.86), sensitivity 0.851, specificity 0.638, and accuracy 0.747 (p <0.001) and can be implemented in practice for the early identification of patients with high cardiovascular risk. Conclusion. Patients with ulcerative colitis exhibit a significant increase in arterial stiffness, which correlates with the degree of inflammatory activity. Endoscopic activity, even in the absence of clinical symptoms, is associated with adverse vascular changes. The developed predictive model, based on three clinical criteria (age >40 years, active ulcerative colitis, and positive family history), could be implemented clinically for the early identification of high cardiovascular risk in this patient population.
Keywords
About the Authors
M. Zh. ZinaidaRussian Federation
Zinaida M. Zhigula — PhD (in Medicine), Associate Professor
Chita
Competing Interests:
The authors declare that this work, its topic, subject matter, and content do not affect any competing interests.
A. A. Zhilina
Russian Federation
Albina A. Zhilina — Dr. Sc. (in Medicine), Vice-Rector for Academic Affairs, Educational Activities and Youth Policy, Professor at the
Chita
Competing Interests:
The authors declare that this work, its topic, subject matter, and content do not affect any competing interests.
N. V. Lareva
Russian Federation
Natalia V. Lareva — Dr. Sc. (in Medicine), Professor, acting Rector, ViceRector for Research and International Cooperation, Head of Department of Therapy of the Faculty of Additional Professional Education
Chita
Competing Interests:
The authors declare that this work, its topic, subject matter, and content do not affect any competing interests.
References
1. Weissman S., Sinh P., Mehta T.I et al Atherosclerotic cardiovascular disease in inflammatory bowel disease: The role of chronic inflammation. World J Gastrointest Pathophysiol. 2020;11(5):104-113. doi: 10.4291/wjgp.v11.i5.104. PMID: 32832194; PMCID: PMC7403753.
2. Gabbiadini R., Dal Buono A., Mastrorocco E. et al Atherosclerotic cardiovascular diseases in inflammatory bowel diseases: to the heart of the issue. Front. Cardiovasc. Med. 10:1143293. doi: 10.3389/fcvm.2023.1143293
3. Sinh P., Cross R.K. Cardiovascular Comorbidities and Inflammatory Bowel Disease: Causes and Consequences. Gastroenterol Hepatol (N Y). 2024 Apr;20(4):204-215. PMID: 38682122; PMCID: PMC11047149.
4. Mironova OI, Isaikina MA, Khasieva SA. Atherosclerosis and cardiovascular risk in patients with inflammatory bowel disease. Ter Arkh. 2021; 93(12):1533-1538. (in Russian). DOI: 10.26442/00403660.2021.12.201225. [In Russian]
5. Vasyuk Yu.A., Ivanova S.V., Shkolnik E.L. Consensus of Russian experts on the evaluation of arterial stiffness in clinical practice. Cardiovascular Therapy and Prevention, 2016: 15(2): 4–19. DOI 10.15829/1728-8800-2016-2-4-19. — EDN VUWMTP [In Russian].
6. Zhigula Z.M., Zhilina A.A., Lareva N.V. Common pathogenetic mechanisms of inflammatory bowel diseases and atherosclerosis: a focus on cytokines. Almanac of Clinical Medicine.2024;52(8):405–416. doi: 10.18786/2072-0505-2024-52-040 [In Russian].
7. Zanoli L., Boutouyrie P., Fatuzzo P. et al Inflammation and Aortic Stiffness: An Individual Participant Data Meta-Analysis in Patients With Inflammatory Bowel Disease. J Am Heart Assoc. 2017 Oct 10;6(10):e007003. doi: 10.1161/JAHA.117.007003.
8. Lipatova T.E., Mihailova E.A., Dudaeva N.G. Cardiovascular risk factors and arterial stiff ness in patients with ulcerative colitis. Saratov Journal of Medical Scientifi c Research 2 019; 15 (3): 753–757 [In Russian].
9. Genkel V.V., Portnova R.G., Antipina T.V. et al Regional Arterial Stiffness in Patients with Inflammatory Bowel Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2019;29(3):66-73. https://doi.org/10.22416/1382-4376-2019-29-3-66-73 [In Russian].
10. Zanoli L., Ozturk K., Cappello C. et al Inflammation and aorticpulse wave velocity: a multicenter longitudinal study in patientswith inflammatory bowel disease. JAmHeartAssoc. 2019;8(3):e010942. doi: 10.1161/JAHA.118.010942.
11. Tarlovskaya E.I., Merezhanova A.A. Daily variability of arterial stiffness of patients with arterial hypertension depending on the category of cardiovascular risk. Kardiologiia. 2018;58(11S):47-57. (In Russ.) https://doi.org/10.18087/cardio.2489 [In Russian].
12. Iazvennyi kolit. Klinicheskie rekomendatsii. 2024. URL: https://cr.minzdrav.gov.ru/view-cr/391_3 (Accessed October 25, 2025) [In Russian].
13. He J., Zhang S., Qiu Y. et al Ulcerative colitis increases risk of hypertension in a UK biobank cohort study. United European Gastroenterol J. 2023 Feb;11(1):19-30. doi: 10.1002/ueg2.12351
14. Mudrov V.A. Roc curve analysis algorithm in biomedical research using SPSS software package. Transbaikalian Medical Bulletin. 2021;(1):148-153. https://doi.org/10.52485/19986173_2021_1_148 [In Russian].
15. Zanoli L., Rastelli S., Inserra G. et al Arterial structure and function in inflammatory bowel disease. World J Gastroenterol. 2015 Oct 28;21(40):11304-11. doi: 10.3748/wjg.v21.i40.11304. PMID: 26523102; PMCID: PMC4616206.
16. Lu Q, Shi R, Mao T. et al Arterial Stiffness in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis. Turk J Gastroenterol. 2021 May;32(5):422-430. doi: 10.5152/tjg.2021.20293. PMID: 34231471; PMCID: PMC8975517.
17. Kucherova N.Yu., Tsyganova Yu.V., Tarasova L.V. The role of the cardio-ankle vascular index CAVI in assessing arterial wall stiffness in patients with ulceral colitis. Experimental and Clinical Gastroenterology. 2024;(11):54-59. https://doi.org/10.31146/1682-8658-ecg-231-11-54-59 [In Russian].
Review
For citations:
Zinaida M.Zh., Zhilina A.A., Lareva N.V. Disease Activity as A Risk Factor for Increased Arterial Stiffness in Patients with Ulcerative Colitis. The Russian Archives of Internal Medicine. 2026;16(3):193-203. (In Russ.) https://doi.org/10.20514/2226-6704-2026-16-3-193-203. EDN: JFHORK
JATS XML




































